Post COVID-19 Condition (Long COVID)
- COVID-19 has left an indelible mark on global health, and while many patients recover fully, a significant number develop post-COVID-19 condition (PCC), also known as long COVID.
- COVID-19 can lead to serious long-term effects, known as post-COVID-19 condition (PCC).
- Millions of people have been affected with post-COVID-19 condition since the beginning of the pandemic.
Understanding Post-COVID-19 Condition: A Comprehensive Look
Table of Contents
COVID-19 has left an indelible mark on global health, and while many patients recover fully, a significant number develop post-COVID-19 condition (PCC), also known as long COVID. This condition is characterized by a range of symptoms that can persist for months or even years, affecting various body systems and significantly impacting daily life.
Key Facts About Post-COVID-19 Condition
- Most patients with COVID-19 recover fully, but some develop post-COVID-19 condition with medium- to long-term effects on one or more body systems.
- Approximately 6 in every 100 people who have COVID-19 develop post-COVID-19 condition.
- While data are limited, the chance of developing post-COVID-19 condition appears to be lower now than earlier in the pandemic. However, the virus is still circulating widely, and every new infection is associated with a risk.
- Fatigue, breathlessness, muscle or joint pain, and impaired sleep are common symptoms of post-COVID-19 condition.
- Health-care providers can guide patients on self-management of symptoms and offer medication for symptom relief or referral for rehabilitation services as needed.
Overview
COVID-19 can lead to serious long-term effects, known as post-COVID-19 condition (PCC). It is also commonly referred to as long COVID. Post-COVID-19 condition is characterized by a range of symptoms which usually start within 3 months of the initial COVID-19 illness and last at least 2 months. PCC can affect a person’s ability to perform daily activities such as work or household chores and restrict social participation.
Scope of the Problem
Millions of people have been affected with post-COVID-19 condition since the beginning of the pandemic. Global estimates indicate that 6 in 100 people with COVID-19 develop post-COVID-19 condition. Estimates largely come from people who suffered COVID-19 early in the pandemic (in the first two years), and there is a very large variation in estimates. More recent research shows the chances of developing post-COVID-19 condition have reduced, but these data are limited and mostly from high-income countries. However, the SARS-CoV-2 virus, the virus that causes COVID-19, is widely circulating and post-COVID-19 condition remains a substantial threat and ongoing challenge to global public health.
Risk Factors
Anyone who was infected with SARS-CoV-2 can develop post-COVID-19 condition. Some people have higher risk. These include women, older adults, smokers, those who are overweight or obese or have pre-existing chronic health problems. Repeated infections and severe COVID-19 needing hospitalization or ICU admission also increase the risk. We see higher numbers of post-COVID-19 condition sufferers among people with disabilities, and where health disparity and access to health care is a problem. Research is ongoing to better understand what causes post-COVID-19 condition. Almost any organ can be affected, including the heart and blood vessels, lungs, nervous system, gut and endocrine (hormone) system. In those with post-COVID-19 condition, researchers have found evidence of persistence of SARS-CoV2 virus in the body, of altered immune responses and autoimmunity, and of formation of microscopic blood clots (micro-thrombosis), among other problems.
Symptoms
Over 200 different symptoms have been reported by people with post-COVID-19 condition. Common symptoms include:
- Fatigue
- Aches and pains in muscles or joints
- Feeling breathless
- Headaches
- Difficulty in thinking or concentrating
- Alterations in taste
Impaired sleep, depression and anxiety also occur. These symptoms might persist from their initial illness or develop after their recovery. Symptoms can be mild to severely debilitating, and affect someone’s capacity to work, perform their daily activities or do exercise.
With increasing understanding of post-COVID-19 condition, some clinical patterns have become clearer. There are symptoms which tend to occur together, for example those related to dizziness and low blood pressure when standing (postural orthostatic tachycardia syndrome (POTS)), symptoms of post exertional malaise, or myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Other medical conditions can occur more often than usual after having COVID-19. These include kidney impairment, heart disease, stroke, diabetes and mental health disorders, among other conditions.
Impact
Post-COVID-19 condition can affect the ability to work and may lead to loss of productivity, and a reduction in income and quality of life. Ongoing medical needs of people with the condition may stretch existing health systems. In the United States, this has led to increased demand for specialized care and rehabilitation services, putting additional strain on the healthcare infrastructure.
Recovery
Symptoms of post-COVID-19 condition generally improve over time, typically 4–9 months. Approximately 15 in 100 people still have symptoms at 12 months.
Treatments
The individual needs of patients with post-COVID-19 condition vary. At the present time, there remains limited research on treatments and a lack of large studies to understand the most effective treatments. However, doctors and their patients may make individualized treatment decisions based on knowledge from similar medical conditions. Health-care providers may offer medications for symptomatic relief as needed. Additionally, newly diagnosed medical problems occurring after COVID-19 frequently have well-established treatments, for example kidney disease or stroke. Many symptoms and functional impairment can be managed effectively by rehabilitation and with careful communication between primary care practitioners and medical specialists.
Self-Care
Education about the importance of quality rest and sleep and skills training on energy conservation techniques can help patients manage their symptoms better. Health-care providers can discuss with patients about self-management strategies to respond promptly to a flare-up or relapse, such as identifying possible triggers, temporarily reducing activity levels, monitoring symptoms over time, and not returning to usual activity levels until the flare-up has resolved. Use of assistive devices and environmental modifications at work and home may be needed in some instances.
Prevention
People can be reinfected with SARS-CoV-2 multiple times. Each time, they have a risk of developing post-COVID-19 condition. Therefore, risk reduction with preventive measures such as the use of masks, personal hygiene and ventilation in high-risk situations continues to be important. Receiving two doses of vaccination appears to reduce the likelihood chance of developing post-COVID-19 condition.
WHO Response
The World Health Organization (WHO) first started work on post-COVID-19 condition in the first wave of the global COVID-19 pandemic in 2020 when reports began to emerge that some patients had persistent symptoms weeks or months following SARS-CoV-2 infection. To better understand this phenomenon, WHO met with patient advocates, researchers, health-care providers, and public health professionals and by September 2020, established emergency international classification of disease (ICD) codes for post-COVID-19 condition.
Since then, WHO has developed a clinical case definition of post-COVID-19 condition to recognize the condition and its impact on people’s lives. This definition was developed by patients, researchers and clinical experts, representing all WHO regions, with the understanding that the definition may change as new evidence emerges and our understanding of the consequences of COVID-19 evolves.
A separate clinical case definition for post-COVID-19 condition in children and adolescents is also available. WHO has been organizing webinars on post-COVID-19 condition since February 2021 to expand understanding of the condition and its impact on patients’ lives, and foster research and collaboration. A global webinar series on the medical management of post-COVID-19 condition is organized each month and has been running since 2023.
A WHO Guideline Development Group consisting of global experts, frontline providers and affected individuals is presently at work on guidelines on diagnosis, treatment and rehabilitation in post-COVID-19 condition. We advocate for governments and funders to support research on post-COVID-19 condition in the interest of improved understanding of this condition around the world, not just in high-income countries, and design optimal clinical care for patients. National authorities are encouraged to plan and budget for multidisciplinary post-COVID-19 condition programmes and to ensure equitable access to relevant therapies.
Recent Developments and Case Studies
Recent studies have shown that the risk of developing post-COVID-19 condition is lower among those who received two doses of the COVID-19 vaccine. This highlights the importance of vaccination in mitigating the long-term effects of the virus. In a study published in BMJ Medicine
, researchers found that vaccination significantly reduced the incidence of long COVID symptoms.
Effect of covid-19 vaccination on long covid: systematic review. BMJ Medicine 2023;2:E000385. doi: 10.1136/BMJMED-2022-000385
In the United States, the Centers for Disease Control and Prevention (CDC) has been actively monitoring the prevalence of post-COVID-19 condition. According to a report published in the MMWR Morbidity and Mortality Weekly Report
, the incidence of long COVID symptoms has decreased over time, but there is still a significant number of people affected.
Ford ND, Slaughter D, Edwards D, et al. Long COVID and Significant Activity Limitation Among Adults, by Age — United States, June 1–13, 2022, to June 7–19, 2023. MMWR Morb Mortal Wkly Rep 2023;72:866–870. DOI: http://dx.doi.org/10.15585/mmwr.mm7232a3
One notable case study involves a 45-year-old woman from New York who developed severe post-COVID-19 condition after contracting the virus in early 2020. Despite multiple hospitalizations and extensive rehabilitation, she continues to experience debilitating fatigue and cognitive impairment. Her story underscores the need for ongoing research and support for those affected by long COVID.
Conclusion
Post-COVID-19 condition is a complex and challenging health issue that requires continued attention and research. While the risk of developing long COVID symptoms has decreased, the condition remains a significant public health concern. Vaccination, preventive measures, and comprehensive healthcare support are crucial in mitigating the impact of this condition. As we continue to learn more about post-COVID-19 condition, it is essential to advocate for equitable access to care and support for all affected individuals.
References
- Al-Aly, Z., Davis, H., McCorkell, L., et al. Long COVID science, research and policy. Nature 30, 2148–2164 (2024). https://doi.org/10.1038/s41591-024-03173-6
- You, T., et al. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA 328, 1604–1615 (2022).
- Ford ND, Slaughter D, Edwards D, et al. Long COVID and Significant Activity Limitation Among Adults, by Age — United States, June 1–13, 2022, to June 7–19, 2023. MMWR Morb Mortal Wkly Rep 2023;72:866–870. DOI: http://dx.doi.org/10.15585/mmwr.mm7232a3.
- Tsampasian, V., et al. Risk factors associated with Post-COVID-19 Condition: A Systematic Review and Meta-analysis. Jama Intern Med 183, (2023).
- Jean P. Hall, Noelle K. Kurth, Lisa McCorkell, and Kelsey S. Goddard, 2024: Long COVID Among People With Preexisting Disabilities. American Journal of Public Health 114, 1261_1264, https://doi.org/10.2105/AJPH.2024.307794
- Peluso MJ, Deeks SG. Mechanisms of long COVID and the path toward therapeutics. Cell. 2024;187(20):5500-5529. doi:10.1016/j.cell.2024.07.054
- The persistence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) after SARS-CoV-2 infection: A systematic review and meta-analysis. Dehlia, Ankush et al. Journal of Infection, Volume 0, Issue 0, 106297
- Bowe, B., Xie, Y. & Al-Aly, Z. Postacute sequelae of COVID-19 at 2 years. Nat Med 29, 2347–2357 (2023). https://doi.org/10.1038/s41591-023-02521-2
- Byambasuren O, Stehlik P, Clark J, et al. Effect of covid-19 vaccination on long covid: systematic review. BMJ Medicine 2023;2:E000385. doi: 10.1136/BMJMED-2022-000385
# Understanding Post-COVID-19 Condition: A Extensive Q&A
## What is Post-COVID-19 Condition (PCC), and how is it defined?
Post-COVID-19 Condition (PCC), often referred to as long COVID, is a condition characterized by symptoms persisting for at least 2 months after the initial COVID-19 illness and generally starting within 3 months of its onset. These symptoms can affect multiple organ systems and considerably impact daily life and social participation.
– According to The Lancet, PCC can lead to severe functional impairment due to organ damage.
– An overview from Canada’s science table emphasizes its complexity and associations with reduced quality of life.
## How common is post-COVID-19 condition?
Approximately 6 out of every 100 COVID-19 survivors develop post-COVID-19 condition. While the likelihood of developing PCC seems to decrease over time and across populations, the risk remains noteworthy due to the ongoing circulation of the SARS-cov-2 virus.
– This global estimate derives largely from data collected in the first two years of the pandemic, with higher incidence reported early on, according to the Canadian Science Brief and Government of Canada’s research.
## What are the symptoms of post-COVID-19 condition?
Over 200 symptoms have been linked to post-COVID-19 condition, but some of the most common include:
– Fatigue
– Breathlessness
– Muscle or joint pain
– Headaches
– Difficulty thinking or concentrating
– Alterations in taste
Symptoms can range from mild to severely debilitating, affecting the ability to work or perform daily activities. This was noted in the Canadian COVID-19 Antibody and Health Survey.
## Who is at a higher risk of developing post-COVID-19 condition?
Anyone infected with SARS-CoV-2 can potentially develop PCC. However,certain groups are at higher risk,such as:
– Women
– Older adults
– Smokers
– Those who are overweight or obese
– Individuals with pre-existing chronic health problems
Severe COVID-19 cases requiring hospitalizations or ICU admissions also increase the risk,as does having repeated infections. Research continues to explore these risk factors further, with some evidence suggesting the persistence of the virus or altered immune responses could contribute to PCC.
## How does post-COVID-19 condition impact daily life and healthcare systems?
Post-COVID-19 condition can significantly impair daily life, reducing one’s ability to work and necessitating ongoing healthcare support.This condition has also placed additional strain on healthcare infrastructures globally, as noted by health systems in the United States and elsewhere.
– The Government of Canada highlights increased demand for specialized care and rehabilitation services among patients with PCC.
## What is known about treating post-COVID-19 condition?
Though research on specific treatments is still ongoing, current strategies emphasize individualized care. Physicians often:
– Provide symptomatic relief with medications
– Refer patients for rehabilitative services
– Utilize knowledge from similar conditions, such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
It’s crucial for care to be coordinated between primary care practitioners and specialists to manage complex symptoms effectively.
## how can patients manage post-COVID-19 condition symptoms?
Self-care strategies are vital for managing PCC symptoms effectively:
– Education on quality rest and sleep
– Training on energy conservation techniques
– Self-management strategies to respond quickly to symptom flare-ups
– Use of assistive devices or making environmental modifications
Healthcare providers play a crucial role in guiding these strategies, ensuring patients have the tools they need to manage their condition proactively.
## how can post-COVID-19 condition be prevented?
Preventive measures significantly reduce the risk of developing post-COVID-19 condition:
– Vaccination: Receiving at least two doses of COVID-19 vaccines has been shown to lower the risk of developing PCC. Studies published in BMJ Medicine indicate this correlation.
– General preventive measures,such as mask-wearing,good personal hygiene,and adequate ventilation in high-risk scenarios,are also crucial.
## What international efforts are being made to address post-COVID-19 condition?
The World Health Association (WHO) has been instrumental in addressing PCC by:
– Working with stakeholders to develop a clinical definition and case classification
– Organizing webinars to expand understanding and collaboration
– Developing guidelines for diagnosis, treatment, and rehabilitation
These efforts aim to ensure equitable access to care and support patients worldwide, according to WHO documentation and ongoing initiatives.
## Conclusion
Post-COVID-19 condition remains a significant public health concern. Understanding its scope, risk factors, and management strategies is crucial in mitigating its impacts. Continued research, vaccination, and comprehensive healthcare support are essential in alleviating the burden of this condition while ensuring equitable care for all affected individuals.
## References
1. Al-Aly, Z., Davis, H.,McCorkell,L., et al. Long COVID science, research and policy.*Nature* 30, 2148–2164 (2024). [Link](https://doi.org/10.1038/s41591-024-03173-6)
2. You, T., et al. Estimated Global proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. *JAMA* 328, 1604–1615 (2022).
3. Ford ND, Slaughter D, Edwards D, et al. Long COVID and Significant Activity Limitation Among Adults, by Age — United States, June 1–13, 2022, to June 7–19, 2023.*MMWR Morb Mortal Wkly Rep* 2023;72:866–870. [Link](http://dx.doi.org/10.15585/mmwr.mm7232a3)
4.Byambasuren O, Stehlik P, Clark J, et al. Effect of COVID-19 vaccination on long COVID: systematic review. *BMJ Medicine* 2023;2:E000385. doi: 10.1136/BMJMED-2022-000385
5. World Health organization documentation and initiatives on post-COVID-19 condition (2020-present).
This comprehensive exploration aims to inform and engage all stakeholders, from patients to healthcare providers, in effectively addressing the ongoing challenges posed by post-COVID-19 condition.